Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257214 · ClinicalTrials.gov registry record · NA
Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder
A NA study of Opioid Use Disorder, sponsored by Philadelphia College of Osteopathic Medicine.
- Active
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 5
- Study locations
NCT04257214 is a NA study of Opioid Use Disorder that is active but no longer recruiting, run by Philadelphia College of Osteopathic Medicine. The registered enrollment target is 340 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 2 states.
The verdict
NCT04257214, a NA study of Opioid Use Disorder, is active but no longer recruiting, sponsored by Philadelphia College of Osteopathic Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 5
- Study locations
Study Summary
Current clinical guidelines for medication assisted treatment (MAT) of opioid use disorder (OUD) recommend that treatment include a psychosocial component to help address psychological factors related to addiction. However, a knowledge gap exists regarding the most effective forms of psychosocial intervention and what interventions are most effective for different types of patients. This gap represents a significant barrier to the widespread implementation of effective office-based opioid treatment (OBOT) with buprenorphine, which is important to improving opioid treatment and responding to the critical needs of individuals living with OUD. The overarching goal of this patient-centered research is to address the diverse needs and preferences of OUD patients in regards to psychosocial approaches and to overcome the "one-size-fits-all" strategies that are typically used to treat OUD. Importantly, investigators arrived at this goal, in part, through collaboration and consultation with former patients who have received different types of treatments for OUD. In this manner, patients provided important insight to inform the selection of interventions to be evaluated, patient characteristics that may differentially impact the effects of the interventions, and the patient outcomes to be examined.
Conditions Studied
Interventions
- BEHAVIORAL Psychosocial treatment
Study Locations (5)
Pennsylvania
- Philadelphia FIGHT - Philadelphia
- Care Clinic - Philadelphia
- Delaware Valley Community Health - Philadelphia
- Berks Community Health Center - Philadelphia
New Jersey
- AtlantiCare - Atlantic City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04257214
The ClinicalTrials.gov registry entry for NCT04257214 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Philadelphia College of Osteopathic Medicine, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial treatment is the first listed.
NCT04257214 reports 5 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, New Jersey.
Frequently Asked Questions
What is clinical trial NCT04257214 about?
NCT04257214 is a clinical study titled "Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder". Current clinical guidelines for medication assisted treatment (MAT) of opioid use disorder (OUD) recommend that treatment include a psychosocial component to help address psychological factors related to addiction. However, a knowledge gap exists regarding the most effective forms of psychosocial in...
What is the current status of trial NCT04257214?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2020-07-15. Estimated completion is 2026-06-30.
What conditions does trial NCT04257214 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04257214?
The interventions under investigation include: Psychosocial treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04257214?
This trial is sponsored by Philadelphia College of Osteopathic Medicine, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04257214 being conducted?
This trial has 5 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.